Work

Effects of the aldehyde dehydrogenase inhibitor disulfiram on the plasma pharmacokinetics, metabolism, and toxicity of benzaldehyde dimethane sulfonate (NSC281612, DMS612, BEN) in mice

Year: 2013

Type: article

Source: Cancer Chemotherapy and Pharmacology

DOI: 10.1007/s00280-013-2296-5

Authors: Robert A. Parise, Jan H. Beumer, Dana M. Clausen, Lora H. Rigatti, Judy A. Ziegler, Maura Gasparetto, Clayton A. Smith, Julie L. Eiseman

Institutions: University of Pittsburgh, UPMC Hillman Cancer Center

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, Cancer Institute, University of Pittsburgh, National Cancer Institute

Awards: G2908934988, Early Clinical Trials of New Anti-Cancer Agents with Phase I Emphasis, Preclinical Pharmacological Studies of Antitumor & Other Therapeutic Agents, G5032682418, Cancer Center Support Grant

OpenAlex ID: W1994773354

FWCI: 0.72

Cites: 28

Cited by: 6

Related to: 10